Feel free to share this newsletter with your friends or colleagues! To subscribe to the GIANT Health newsletter, click here


Hello <<First Name>>!


GIANT's "5000 women Campaign"

For over 6 years GIANT Health has been a passionate "Opportunity creating platform for women" . There is no other leading international health-tech event that features so many women on stage, gives free tickets to so many young female STEM subject students & junior doctors, and more.
GIANT is announcing an important and exciting new leadership role for our "5000 Women Campaign".

We're recruiting a talented woman to drive GIANT's 2020 Diversity Programme. 

Click here to find out more about the role.

Don't hesitate and ask us for more information!

Barry Shrier, Founder, GIANT Health
+44 7776 132 517


GP patients to be offered whole-genome screening in UK-first study
A “pioneering study” to assess the benefits of screening for gene faults will see people in the UK have their entire genetic code read from samples taken at a GP practice for the first time. Researchers hope to determine whether whole-genome sequencing in a healthy population can have a significant impact on people’s health by helping diagnose cancer, heart disease and other illnesses much earlier. Read more...
Amazon launches Transcribe Medical to its US audience
Amazon last week unveiled Transcribe Medical to its US audience, a speech recognition tool to make clinical documentation more efficient. The company said the tool will make it easier for developers to integrate medical transcriptions into applications. In the company announcement Amazon said “It can automatically and accurately transcribe physicians’ dictations, as well as their conversations with patients, into text. The service enables automatic punctuation and capitalisation, allowing physicians to speak naturally when transcribing voice notes.” Read more...


Current Health, Scotland (UK)
  • £9 million 💸
  • Led by Legal & General
  • Series A funding

Current Health the remote patient monitoring platform has raised £9 million in Series A funding. Founded in Scotland in 2015 by CEO Christopher McCann and CTO Stewart Whiting, Current Health uses wearable and wireless vital signs monitoring, clinical indicators from an ecosystem of more than 50 integrations and symptoms collected via its patient engagement tools, to continuously track patient health trends. Leveraging proprietary machine learning algorithms, the company’s platform analyses this data to proactively detect illness and alert providers to high-risk patients so they can deliver healthcare earlier. Read more...

Anaconda Biomed, Barcelona (ES)
  • €20 million 💸
  • Led by Asabys Partners 
  • Series A funding
Anaconda Biomed S.L., a Barcelona, Spain-based medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, closed €20m in new funding. The company intends to use the funds for clinical studies of its technology, regulatory submissions in international markets, further product development and manufacturing scale-up. Anaconda Biomed has already enrolled 14 patients in a 125-patient first-in-human study.
Thrive is an award-winning agency pioneering behaviour change and specialising in wellbeing. They work with corporates, NGOs, charities and governments to improve the health of millions, reaching 50 million people in 10 countries with our online content.
Direct to consumer health content is key to managing healthcare costs. Teamed with behaviour change principles, it can empower people to manage their health rather than let their health manage them. And technology can deliver this health help at scale.

Want to know more about Thrive? Click here

Reasons to be cheerful, PART 3:

Social Media is used to boost cancer screening rates. The tests showed that there was a 12.9% increase of screening services! Read more
A platform for UK's
fast-growing companies.

Beauhurst is building the essential tool for learning about high-growth companies. Discover comparables, conduct due diligence and retain key clients with detailed information on every high-growth company and transaction. Analyse the most comprehensive data on high-growth companies in the UK, and the funds, accelerators and people that support them. Read more

Meet our partners


Dosage is on a mission to share the fantastic world of cannabis culture and general health and wellness, seen through the eyes of science and with an open-minded and holistic attitude. Our mission is to inspire and enlighten through the power of knowledge. Find out more


UK5G is the national innovation network dedicated to the promotion of research, collaboration and the commercial application of 5G in the UK.  It is a ‘network of networks’ that enhances links between R&D activities undertaken by different organisations across telecoms and industry, including the UK Government’s 5G Testbeds and Trials Programme.  UK5G is independent and impartial, supported by a senior national advisory board who provide expert feedback to Government from industry, identifying their priorities and advising on future areas of focus. Find out more

GIANT Health 2019 - Highlight video
GIANT Health reaches thousands of members of the global HealthTech community. Get in touch to discuss partnership opportunities. 

Barry Shrier, Founder, GIANT Health
@Barry_HealthTec | +44 7776 132 517

PS: If you're recruiting, looking for a hospital trial partner, in fundraising mode, looking for a job...please get in touch and we'll be happy to support you in this newsletter. 
GIANT would like to thank our sponsors for their support, you guys are great!
We are writing to you because we consider you a valuable member of the global health tech community.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GIANT Health Event · 1-6 Speedy Place · Cromer Street · London, London WC1H 8BS · United Kingdom